Dip0f 0001 01
Diprivan Injection, Emulsion
Product Images NDC 65219-800
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diprivan (NDC 65219-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Dip0f 0001 02
Dip0f 0001 03
Dip0f 0001 04
This is a description of a sterile and non-pyrogenic solution containing EDTA, which prevents microbial growth for up to 12 hours after opening. The solution is for intravenous administration and should be used with strict aseptic technique. Dosage information is available in the package insert. The solution must be stored between 4°C to 25°C and should not be frozen. The solution is made in Sweden and manufactured for Fresenius Kabi in Lake Zurich, IL, USA. The product is called Diprivan and has a concentration of 0 mg per 20 mL (10 mg per ml) and is for single-patient use only.*
Dip0f 0001 05
This is an output of a drug label for DIPRIVAN. It is for the 200mg per 20 mL injectable solution of Propofol, for intravenous administration only. The drug vials should be shaken well before use. The dosage and administration should be performed only by a trained healthcare professional. The label includes the NDC (National Drug Code) numbers, manufacturing details, precautions and contraindications.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
